{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:09:04Z","timestamp":1787069344829,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jpba.2022.114875","type":"journal-article","created":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T01:56:13Z","timestamp":1654307773000},"page":"114875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Development and application of amphotericin B immunoassay for pharmacokinetic studies and therapeutic drug monitoring in critically ill patients"],"prefix":"10.1016","volume":"218","author":[{"given":"Maksim A.","family":"Burkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri A.","family":"Surovoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera G.","family":"Arzumanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna A.","family":"Galvidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpba.2022.114875_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40121-020-00382-7","article-title":"Sixty years of amphotericin B: an overview of the main antifungal agent used to treat invasive fungal infections","volume":"10","author":"Cavassin","year":"2021","journal-title":"Infect. Dis. Ther."},{"issue":"2","key":"10.1016\/j.jpba.2022.114875_bib2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/21505594.2016.1257457","article-title":"New facets of antifungal therapy","volume":"8","author":"Chang","year":"2017","journal-title":"Virulence"},{"issue":"3","key":"10.1016\/j.jpba.2022.114875_bib3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.diagmicrobio.2013.04.001","article-title":"Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex","volume":"76","author":"Wade","year":"2013","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"2","key":"10.1016\/j.jpba.2022.114875_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/jof6020066","article-title":"Encochleated amphotericin B: Is the oral availability of amphotericin B finally reached?","volume":"6","author":"Aigner","year":"2020","journal-title":"J. Fungi"},{"issue":"6","key":"10.1016\/j.jpba.2022.114875_bib5","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1021\/acs.molpharmaceut.9b00809","article-title":"Preparation, characterization, and formulation optimization of ionic-liquid-in-water nanoemulsions toward systemic delivery of amphotericin B","volume":"17","author":"Esson","year":"2020","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.jpba.2022.114875_bib6","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1021\/acsinfecdis.0c00068","article-title":"Discovery of amphamide, a drug candidate for the second generation of polyene antibiotics","volume":"6","author":"Tevyashova","year":"2020","journal-title":"ACS Infect. Dis."},{"issue":"1","key":"10.1016\/j.jpba.2022.114875_bib7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/phar.2348","article-title":"Altered pharmacokinetics and dosing of liposomal amphotericin B and isavuconazole during extracorporeal membrane oxygenation","volume":"40","author":"Zhao","year":"2020","journal-title":"Pharmacother.: J. Hum. Pharmacol. Drug Ther."},{"key":"10.1016\/j.jpba.2022.114875_bib8","doi-asserted-by":"crossref","first-page":"782131","DOI":"10.3389\/fchem.2021.782131","article-title":"Sensitive LC-MS\/MS methods for amphotericin B analysis in cerebrospinal fluid, plasma, plasma ultrafiltrate, and urine: application to clinical pharmacokinetics,","volume":"9","author":"Pippa","year":"2021","journal-title":"Front. Chem."},{"issue":"3","key":"10.1016\/j.jpba.2022.114875_bib9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00007691-200106000-00015","article-title":"Quantitation of free and total amphotericin B in human biologic matrices by a liquid chromatography tandem mass spectrometric method","volume":"23","author":"Lee","year":"2001","journal-title":"Ther. Drug Monit."},{"issue":"11","key":"10.1016\/j.jpba.2022.114875_bib10","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.tibtech.2020.03.001","article-title":"On-site therapeutic drug monitoring","volume":"38","author":"Ates","year":"2020","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jpba.2022.114875_bib11","doi-asserted-by":"crossref","unstructured":"S.K. Vashist, J.H. Luong, Immunoassays: An Overview, Handbook of Immunoassay Technologies, Elsevier2018, pp. 1\u201318.","DOI":"10.1016\/B978-0-12-811762-0.00001-3"},{"issue":"12","key":"10.1016\/j.jpba.2022.114875_bib12","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1128\/jcm.33.12.3154-3158.1995","article-title":"Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and-susceptible isolates of Candida albicans","volume":"33","author":"Espinel-Ingroff","year":"1995","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jpba.2022.114875_bib13","unstructured":"CLSI, Reference method for broth dilution antifungal susceptibility testing of yeasts, approved standard. CLSI document M27-A3 Clinical and Laboratory Standards Institute, Wayne, PA 2008."},{"key":"10.1016\/j.jpba.2022.114875_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114275","article-title":"Development of ELISA formats for polymyxin B monitoring in serum of critically ill patients","volume":"204","author":"Burkin","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2022.114875_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.112952","article-title":"Determination of total and free voriconazole in human plasma: application to pharmacokinetic study and therapeutic monitoring","volume":"178","author":"Resztak","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"6","key":"10.1016\/j.jpba.2022.114875_bib16","first-page":"1755","article-title":"Selective immunodetection of difloxacin in animal muscles and sera: role of hapten orientation, food analytical","volume":"10","author":"Galvidis","year":"2017","journal-title":"Methods"},{"issue":"9","key":"10.1016\/j.jpba.2022.114875_bib17","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1134\/S0003683818090120","article-title":"Immunochemical and protective properties of conjugated capsular polysaccharide of streptococcus pneumoniae serotype 9N","volume":"54","author":"Nuriev","year":"2018","journal-title":"Appl. Biochem. Microbiol."},{"key":"10.1016\/j.jpba.2022.114875_bib18","doi-asserted-by":"crossref","unstructured":"K.C. Gray, D.S. Palacios, I. Dailey, M.M. Endo, B.E. Uno, B.C. Wilcock, M.D. Burke, Amphotericin primarily kills yeast by simply binding ergosterol, Proceedings of the National Academy of Sciences 109(7) (2012) 2234\u20132239.","DOI":"10.1073\/pnas.1117280109"},{"issue":"1","key":"10.1016\/j.jpba.2022.114875_bib19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/09540105.2020.1733935","article-title":"Development of indirect competitive enzyme-linked immunoassay of colistin for milk and egg analysis","volume":"31","author":"Galvidis","year":"2020","journal-title":"Food Agric. Immunol."},{"issue":"2","key":"10.1016\/j.jpba.2022.114875_bib20","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.foodcont.2013.05.001","article-title":"Immunochemical detection of apramycin as a contaminant in tissues of edible animals","volume":"34","author":"Burkin","year":"2013","journal-title":"Food Control"},{"key":"10.1016\/j.jpba.2022.114875_bib21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jim.2012.12.002","article-title":"Hapten modification approach for switching immunoassay specificity from selective to generic","author":"Burkin","year":"2013","journal-title":"J. Immunol. Methods 388(1-2)"},{"issue":"3","key":"10.1016\/j.jpba.2022.114875_bib22","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1021\/acs.biomac.1c01451","article-title":"Covalent conjugation of amphotericin B to hyaluronic acid: an injectable water-soluble conjugate with reduced toxicity and anti-leishmanial potential","volume":"23","author":"Silva-Carvalho","year":"2022","journal-title":"Biomacromol."},{"issue":"15","key":"10.1016\/j.jpba.2022.114875_bib23","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.biomaterials.2003.09.080","article-title":"Conjugation of amino-containing drugs to polysaccharides by tosylation: amphotericin B\u2013arabinogalactan conjugates","volume":"25","author":"Ehrenfreund-Kleinman","year":"2004","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.jpba.2022.114875_bib24","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/AAC.44.3.546-550.2000","article-title":"A sensitive amphotericin B immunoassay for pharmacokinetic and distribution studies","volume":"44","author":"Machard","year":"2000","journal-title":"Antimicrob. Agents Ch"},{"issue":"5","key":"10.1016\/j.jpba.2022.114875_bib25","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/jac\/dkac021","article-title":"Comparative polymyxin B pharmacokinetics in patients receiving extracorporeal membrane oxygenation","volume":"77","author":"Surovoy","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.jpba.2022.114875_bib26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1128\/AAC.40.3.609","article-title":"Pharmacokinetics of conventional formulation versus fat emulsion formulation of amphotericin B in a group of patients with neutropenia","volume":"40","author":"Ayestar\u00e1n","year":"1996","journal-title":"Antimicrob. Agents Ch"},{"issue":"6","key":"10.1016\/j.jpba.2022.114875_bib27","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1128\/AAC.26.6.824","article-title":"Induction of amphotericin B-specific antibodies for use in immunoassays","volume":"26","author":"Little","year":"1984","journal-title":"Antimicrob. Agents Ch"},{"issue":"12","key":"10.1016\/j.jpba.2022.114875_bib28","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1128\/AAC.33.12.2092","article-title":"Antibodies to nystatin demonstrate polyene sterol specificity and allow immunolabeling of sterols in Saccharomyces cerevisiae","volume":"33","author":"Walker-Caprioglio","year":"1989","journal-title":"Antimicrob. Agents Ch"},{"issue":"3","key":"10.1016\/j.jpba.2022.114875_bib29","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1128\/AAC.40.3.637","article-title":"Amphotericin B enzyme-linked immunosorbent assay","volume":"40","author":"Cleary","year":"1996","journal-title":"Antimicrob. Agents Ch"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522002965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522002965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:21:45Z","timestamp":1760001705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708522002965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":29,"alternative-id":["S0731708522002965"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2022.114875","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and application of amphotericin B immunoassay for pharmacokinetic studies and therapeutic drug monitoring in critically ill patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2022.114875","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114875"}}